Agenus | AGEN - Bienes





Bienes Cambio Fecha
AbbVie USD 136.46B 2.5B 2026-03
Agenus USD 186.46M 40.34M 2026-03
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Celldex Therapeutics USD 511.25M 71.73M 2026-03
CSL USD 37.9B 1.5B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Glaxosmithkline GBP 82.34B 102.25M 2025-12
Incyte USD 7.34B 381.14M 2026-03
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 200.89B 1.68B 2026-03
Jiangsu Hengrui CNY 71.29B 1.43B 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
MacroGenics USD 217.87M 38.97M 2026-03
Merck EUR 53.07B 1.54B 2026-03
Merck USD 128.68B 8.18B 2026-03
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Novartis USD 118.53B 7.58B 2026-03
Novavax USD 1.04B 133.35M 2026-03
Pfizer USD 207.62B 542M 2026-03
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Veracyte USD 1.44B 30.38M 2026-03